Lu-177-PSMA-617 approved by FDA for prostate cancer patients
Novartis has obtained US Food and Drug Administration (FDA) marketing [...]
Novartis has obtained US Food and Drug Administration (FDA) marketing [...]
Novel Radioligand Therapy Proven Superior for Metastatic Prostate Cancer Patients [...]